Dr. James N Glenn, M.D. Orthopaedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1301 W 12th Ave, Ste 105, Emporia, KS 66801 Phone: 620-343-1191 Fax: 620-343-3139 |
News Archive
Americans for Tax Reform today released an analysis showing the impact on Massachusetts of Marsha Coakley's support for the Senate healthcare bill. Coakley is on record supporting the Senate government healthcare bill, which contains eighteen separate tax increases. One of these is a new $2 billion per year (rising to $3 billion in 2017) tax on medical device manufacturers.
A new therapeutic being tested by University of Alberta researchers is showing early promise as a more effective treatment that could help nearly half of patients with Duchenne muscular dystrophy.
In cases of severe ocular trauma involving the cornea, wound healing occurs following intervention, but at the cost of opaque scar tissue formation and damaged vision. Recent research has shown that mesenchymal stem cells (MSCs) — which can differentiate into a variety of cells, including bone, cartilage, muscle and fat cells — are capable of returning clarity to scarred corneas; however, the mechanisms by which this happens remained a mystery — until now.
Merck has thoroughly reviewed the safety data for sitagliptin, and sitagliptin was not associated with an increase in the incidence of pancreatitis in preclinical studies or in clinical trials of up to two years in duration with more than 6,000 patients.
Encision Inc., a medical device company owning patented surgical technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, today announced financial results for its fiscal 2016 first quarter that ended June 30, 2015.
› Verified 7 days ago